The price already assumes free cash flow shrinks

The current price sits on the bear scenario in which free cash flow slowly shrinks, so a base case where free cash flow merely holds flat is worth roughly 38% more, and the stock needs an end to decline rather than a return to growth. These are growing-perpetuity values on the guided ~$11.15B of FY2026 free cash flow at a 9% cost of equity. The counter sits in the same arithmetic: at a ~12% cost of equity even a no-growth Accenture is worth only about $93B — roughly the price — so the whole read is discount-rate dependent, and peers already describe the industry's AI revenue compression as 'quite substantial.'

The pay plan rewards bought growth like organic growth

• The record: acquisitions lifted goodwill to ~72% of equity and cut return on equity from 31% to 25% since FY2022; the ~$9.1B of book equity added earned only ~9% GAAP, near 14% adjusted, against a ~25% base return.
• The metric: the CEO's largest pay component vests 75% on operating income with no measure of return on capital, so a dollar earned by acquisition scores like a dollar grown in-house — and FY2026 deal spend is guided near $9B.
• The counterweight: operating income is a profit line, so unprofitable revenue cannot hit target; a quarter of the award rides on relative shareholder return; the 2022 award vested at 88.2%, and reported CEO pay fell from $33.7M to $24.9M at 30th-percentile returns.

AI is both the demand and the threat, and the numbers do not yet decide

• The tailwind: advanced-AI revenue tripled to $2.7B in FY2025 on $5.9B of bookings and 77,000 AI professionals — but that is still under 4% of the $69.7B base, too small to offset a core guided to 3–4% growth.
• The threat: the same tools compress the billable hours behind the other 96%, so management is re-engineering toward non-FTE, platform pricing and has booked ~$865M of restructuring to rotate the workforce around AI.
• The tell: headcount is decoupling from revenue — FY2025 revenue rose 7.4% on 0.6% more people — but the recent per-head gains lean on talent-mix rotation, not yet proven automation leverage.

Growth fell from 22% to a guided 3–4%, and half of it is bought

Before: revenue compounded at double digits for most of a decade, peaking near 22% in FY2022.

Now: growth collapsed to ~1% in FY2024, recovered to 7% in FY2025, and is guided to 3–4% local currency for FY2026 — with a ~1.5-point drag from a U.S. federal air-pocket management expects to reverse in the August quarter.

Underneath: roughly 1.5 points of the guided growth is inorganic, so the organic core is compounding at only ~1.5–2.5%; Consulting — the discretionary front end where AI deflation would surface first — slowed to 1%.

FY2026 is a step-change: $18.5B deployed, above cash flow, on first-ever debt

• The engine: ~$14B across 132 tuck-in acquisitions over FY2022–FY2025 lifted goodwill from $13.1B to $22.5B with no impairment — evidence the deals were additive, with the caveat that impairment is a lagging signal.
• The step-change: FY2026 plans ~$9B of M&A plus at least $9.5B of shareholder returns — about $18.5B against ~$11B of free cash flow — funded by the first real debt in the company's history, a $5B senior-notes issue.
• The returns: the dividend rose 10% to $1.63 a quarter, but buybacks mostly offset equity-comp dilution; the open question is what return the bought growth earns as goodwill nears three-quarters of equity.